About 2,500 diabetic test strips used specifically by health care providers are being recalled because they may report falsely low blood glucose levels. Because the tests trips are reporting falsely low blood glucose when the true levels are above 265 mg/dL, there is a risk that the health care provider would not diagnose hyperglycemia (high blood sugar) including diabetic ketoacidosis and hyperosmolar hyperglysemic syndrome in a timely manner and fail to treat elevated blood glucose levels. The recall involves the SPOTCHEM II Basic PANEL-1 Reagent Test Strips and SPOTCHEM II Glucose Reagent Test Strips, manufactured by Arkray Factory Inc., with ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.